Mackenzie Financial’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.9M Buy
521,331
+10,402
+2% +$102K 0.01% 790
2026
Q1
$3.22M Buy
510,929
+339,020
+197% +$3.05M ﹤0.01% 814
2025
Q4
$1.85M Buy
171,909
+25,414
+17% +$279K ﹤0.01% 898
2025
Q3
$1.83M Buy
+146,495
New +$1.5M ﹤0.01% 865
2025
Q1
Sell
-29,172
Closed -$229K 1709
2024
Q4
$229K Buy
29,172
+8,273
+40% +$41.5K ﹤0.01% 1505
2024
Q3
$65.8K Buy
+20,899
New +$61.5K ﹤0.01% 1519
2021
Q4
Sell
-2,212
Closed -$213K 1448
2021
Q3
$213K Buy
+2,212
New +$241K ﹤0.01% 1293

Other funds holding CRNC

Mackenzie Financial's CRNC Position: Q2 2026 in Review

Mackenzie Financial increased its Cerence (CRNC) stake by 2% in Q2 2026, buying an estimated $102K and bringing the position to 521,331 shares worth $5.9M. The position accounts for 0.01% of the portfolio, ranked #790.

Mackenzie Financial first reported a position in CRNC in Q3 2021 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Mackenzie Financial held 521,331 shares of Cerence worth $5.9M as of Q2 2026.
  • Mackenzie Financial bought 10,402 Cerence shares in Q2 2026, an estimated $102K.
  • Cerence made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #790 holding.
  • Mackenzie Financial first reported a position in Cerence in Q3 2021 and has held it in 7 quarters since.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.